Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Rhabdomyosarcoma 1Neoplasms 1Myelodysplastic Syndromes 1Microphthalmia, Isolated, with Coloboma 5 1Medulloblastoma 1Leukemia, Myelomonocytic, Chronic 1Fanconi Anemia 1Desmoplastic Small Round Cell Tumor 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Vincristine 4Etoposide 4Doxorubicin 4Cyclophosphamide 4Thiotepa 3Temozolomide 3Ifosfamide 3Filgrastim 3Cisplatin 3fludarabine phosphate 2Radiotherapy 2Melphalan 2Irinotecan 2Hyperthermic Intraperitoneal Chemotherapy 2Granulocyte Colony-Stimulating Factor 2Cytoreduction Surgical Procedures 2Brachytherapy 2thymoglobulin 1temsirolimus 1sodium thiosulfate 1prexasertib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1pazopanib 1pasireotide 1fludarabine 1Zoledronic Acid 1X-Rays 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Desmoplastic Small Round Cell Tumor × prexasertib × Clear all
NCT04095221 2025-02-20

A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
21 enrolled
Sarcoma

Rhabdomyosarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡